GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
1.4k
c/glp1canada·posted 1 year ago by u/erez_baptista

[Discussion] special authorization is doing more work than we give it credit for

Discussion Cold Box ×4 Sourced ×2

Thinking out loud about this: special authorization is doing more work than we give it credit for.

Cash pricing, which people skip because they assume coverage is the only route.

Prices at the counter vary between pharmacies, sometimes substantially, in the same city. Members here have found spreads worth a real amount per month by ringing four places and asking for the cash price of a specific presentation.

That does not make coverage unimportant. It does mean that while an authorization is in process — which can take weeks — knowing the actual cash spread is worth half an hour of phone calls. Post what you find with the province and the month; the comparison threads here work for exactly the same reason the UK pricing tracker does.

National regulatory approval establishes that a product may be sold. Whether any plan pays for it is a separate decision, and public drug plans are administered provincially.

Special authorization is a documented exception process with published criteria. Applications that answer those criteria explicitly, point by point, fare better than general clinical narratives.

That is everything I have. The rest is opinion and I have tried to keep it out.

1,517 up / 167 down90% upvoted66 commentsid i0p9xa14 Mar 2025

66 comments

27 in this archive, depth 3

best — the order this archive was captured in

u/omar_eriksen101 points·1 year ago

A rejected claim at the pharmacy counter and a denied authorization are different events with different remedies. The first can be an administrative or quantity issue; the second is a determination you can appeal.

replysharereportpermalink
u/greta_perrin55 points·1 year ago

Right, and the pharmacist can usually give a definite answer faster than a week of forum speculation.

replysharereportpermalink
u/greta_perrin17 points·1 year ago·edited

Have you seen the special authorization criteria for your province?

replysharereportpermalink
u/food_noise_gonemaintenance5 points·1 year ago

Formulary criteria are revised, and plan renewal is a natural point at which a previously refused request may succeed without anything about the applicant changing.

replysharereportpermalink
u/a1c_arcT2D46 points·1 year ago

Nothing here is medical or legal advice. The pharmacist and the prescriber are the people who can act, and both are faster than a forum.

replysharereportpermalink
u/erez_baptistaOP31 points·1 year ago

a denial letter names a criterion, that is your handle

replysharereportpermalink
u/erez_baptistaOP-27 points·1 year ago

Compared cash prices across four pharmacies before pursuing coverage and the spread was larger than I expected.

replysharereportpermalink
u/elin_varga9 points·1 year ago·edited

Employer-sponsored plans have their own criteria and appeal processes, independent of the provincial formulary. Which one applies determines everything about the route.

replysharereportpermalink
u/lane_watcherMOD38 points·1 year ago

Province added to the title. Coverage is provincial and the thread could not be answered without it.

replysharereportpermalink
u/ahmed_rasmussen12 points·1 year ago

ask the pharmacy what the cash price is, it varies

replysharereportpermalink
u/lipid_panel_larrybloodwork26 points·1 year ago

Kept every form and reference number. When they had no record of a submission, I did.

replysharereportpermalink
u/rania_diallo20 points·1 year ago

Was this a denied authorization or a rejected claim?

replysharereportpermalink
u/aksel_palacios14 points·1 year ago

Correction: that is regulatory approval, not coverage. They are separate decisions by separate bodies.

replysharereportpermalink
u/search_before_post8 points·1 year ago

Correction: that is regulatory approval, not coverage.

Agreed — write the application against the published criteria rather than around them.

replysharereportpermalink
u/dose_diary_danalog keeper11 points·1 year ago

I would not read one pharmacy’s cash price as the going rate. The spread is real.

replysharereportpermalink
u/erez_baptistaOP8 points·1 year ago

Those criteria were revised at renewal, so the version quoted upthread is out of date.

replysharereportpermalink
u/liv_dumitru17 points·1 year ago

Which province?

replysharereportpermalink
u/ahmed_rasmussen9 points·1 year ago

That is an employer plan process, and the provincial route is different in both form and timeline.

replysharereportpermalink
u/fasting_insulin_f3 points·1 year ago

formulary decisions are provincial, so the province is the first fact

replysharereportpermalink
u/zeynep_duarte6 points·1 year ago

the criteria change at plan renewal and nobody announces it

replysharereportpermalink
u/milos_vestergaard9 points·1 year ago

compare cash prices before assuming coverage is the only path

replysharereportpermalink
u/isabela_guerrero5 points·1 year ago

Quantity limits restrict how much may be dispensed in a period even where coverage exists. They are a distinct barrier and require a distinct request.

replysharereportpermalink
u/gradient_goblin3 points·1 year ago·edited

What did the denial actually say?

replysharereportpermalink
u/sequence_checkerresearch peptides2 points·1 year ago

Same view — private and provincial plans are genuinely different processes with different appeal routes.

replysharereportpermalink
u/ignacio_silva4 points·1 year ago

the exception drug status route exists in several provinces

replysharereportpermalink
u/greta_lokken4 points·1 year ago

the pharmacist is often the fastest route to a definite answer

replysharereportpermalink
u/emil_barros2 points·1 year ago

Yes. Cash prices vary and comparing them before assuming coverage is the only route is worth doing.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1canada

Canadian access: provincial formulary differences, private plan coverage, the special-authorisation process, cross-border pricing arbitrage and why the Ontario answer is not the Alberta answer.

17kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/glp1canada rules
  1. Name your province. Coverage is provincial.
  2. Private plan details: redact your group number.
  3. No cross-border purchasing instructions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.